Description
Product Description: Discover Letrozole 2.5 mg, a nonsteroidal aromatase inhibitor that effectively blocks the conversion of androgens to estrogen. Unlike ovariectomy, the use of Letrozole 2.5 mg does not trigger a rise in serum FSH levels. This medication selectively inhibits gonadal steroid production without majorly impacting adrenal mineralocorticoid or glucocorticoid synthesis. Letrozole 2.5 mg competes for binding to heme in the cytochrome P450 subunit of the aromatase enzyme, leading to reduced estrogen production throughout the body. Treatment with Letrozole 2.5 mg significantly lowers serum levels of estrone, estradiol, and estrone sulfate, while minimally affecting adrenal corticosteroid, aldosterone, or thyroid hormone synthesis.